Abstract
Liver resection is integrated in the oncological surgical management of metastatic gastrointestinal and neuroendocrine tumours. However, the good prognosis reached in these cases has not been obtained for metastatic tumours of other histological types. In this review, we analysed the published case reports and series of hepatectomies in patients with metastatic breast cancer, melanoma, sarcoma, genitourinary tumours, pulmonary and adrenocortical tumours. From the reported data the surgical resection of oligometastases yields good results in terms of improved survival, in particular when the disease-free time period is longer than 1 year. Hepatic resection can be a valid surgical strategy to obtain a survival benefit in patients with liver metastases from non-gastrointestinal, non-neuroendocrine tumours. However, a careful patient selection is needed in order to obtain a real survival benefit; patients with a good performance status, with a disease-free period longer than 1 year and with oligometastases may obtain the best advantage from this approach.
Similar content being viewed by others
References
Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K, Takayama T, Makuuchi M (2003) One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 138(11):1198–1206
Cescon M, Vetrone G, Grazi GL, Ramacciato G, Ercolani G, Ravaioli M, Del Gaudio M, Pinna AD (2009) Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years. Ann Surg 249(6):995–1002
Aloya TA, Vauthey JN, Ribero D, Pawlik TM, Wei SH, Curley SA, Zorzi D, Abdalla EK (2006) Solitary colorectal liver metastases: resection determines outcome. Arch Surg 141:460
Macedo FI, Makarawo T (2014) Colorectal hepatic metastases: evolving therapies. World J Hepatol 6(7):453–463
Frilling A, Modlin IM, Kidd M, Russell C, Breitenstein S, Salem R, Kwekkeboom D, Lau WY, Klersy C, Vilgrain V, Davidson B, Siegler M, Caplin M, Solcia E, Schilsky R, Working Group on Neuroendocrine Liver Metastases (2014) Recommendations for management of patients with neuroendocrine liver metastases. Lancet Oncol 15(1):e8–e21
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90
Elias D, Di Pietroantonio D (2006) Surgery for liver metastases from breast cancer. HPB Oxf 8(2):97–99
Elias D, Maisonnette F, Druet-Cabanac M, Ouellet JF, Guinebretiere JM, Spielmann M, Delaloge S (2003) An attempt to clarify indications for hepatectomy for liver metastases from breast cancer. Am J Surg 185(2):158–164
Pocard M, Pouillart P, Asselain B, Falcou MC, Salmon RJ (2001) Hepatic resection for breast cancer metastases: results and prognosis (65 cases). Ann Chir 126(5):413–420
Sakamoto Y, Yamamoto J, Yoshimoto M, Kasumi F, Kosuge T, Kokudo N, Makuuchi M (2005) Hepatic resection for metastatic breast cancer: prognostic analysis of 34 patients. World J Surg 29(4):524–527
Adam R, Aloia T, Krissat J, Brale MP, Paule B, Giacchetti S, Delvart V, Azoulay D, Bismuth H, Castaing D (2006) Is liver resection justified for patients with hepatic metastases from breast cancer? Ann of Surg 244(6):897–907
Thelen A, Benckert C, Jonas S, Lopez-Hänninen E, Sehouli J, Neumann U, Rudolph B, Neuhaus P (2008) Liver resection for metastases from breast cancer. J Surg Oncol 97(1):25–29
Kollmar O, Moussavian MR, Richter S, Bolli M, Schilling MK (2008) Surgery of liver metastases in gynecological cancer—indication and results. Onkologie 31(7):375–379
Hoffmann K, Franz C, Hinz U, Schirmacher P, Herfarth C, Eichbaum M, Büchler MW, Schemmer P (2010) Liver resection for multimodal treatment of breast cancer metastases: identification of prognostic factors. Ann Surg Oncol 17(6):1546–1554
Abbott DE, Brouquet A, Mittendorf EA, Andreou A, Meric-Bernstam F, Valero V, Green MC, Kuerer HM, Curley SA, Abdalla EK, Hunt KK, Vauthey JN (2012) Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome. Surgery 151(5):710–716
Van Walsum GA, de Ridder JA, Verhoef C, Bosscha K, van Gulik TM, Hesselink EJ, Ruers TJ, van den Tol MP, Nagtegaal ID, Brouwers M, van Hillegersberg R, Porte RJ, Rijken AM, Strobbe LJ, de Wilt JH, Dutch Liver Surgeons Group (2012) Resection of liver metastases in patients with breast cancer: survival and prognostic factors. Eur J Surg Oncol 38(10):910–917
Groeschl RT, Nachmany I, Steel JL, Reddy SK, Glazer ES, de Jong MC, Pawlik TM, Geller DA, Tsung A, Marsh JW, Clary BM, Curley SA, Gamblin TC (2012) Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysis. J Am Coll Surg 214(5):769–777
Dittmar Y, Altendorf-Hofmann A, Schüle S, Ardelt M, Dirsch O, Runnebaum IB, Settmacher U (2013) Liver resection in selected patients with metastatic breast cancer: a single-centre analysis and review of literature. J Cancer Res Clin Oncol 139(8):1317–1325
Kostov DV, Kobakov GL, Yankov DV (2013) Prognostic factors related to surgical outcome of liver metastases of breast cancer. J Breast Cancer 16(2):184–192
Ehrl D, Rothaug K, Hempel D, Rau HG (2013) Importance of liver resection in case of hepatic breast cancer metastases. Hepatogastroenterology 60:2026–2033
Mariani P, Servois V, De Rycke Y, Bennet SP, Feron JG, Almubarak MM, Reyal F, Baranger B, Pierga JY, Salmon RJ (2013) Liver metastases from breast cancer: surgical resection or not? A case-matched control study in highly selected patients. EJSO 39:1377–1383
Bacalbasa N, Dima SO, Purtan-Purnichescu R, Herlea V, Popescu I (2014) Role of surgical treatment in breast cancer liver metastases: a single center experience. Anticancer Res 34:5563–5566
Weinrich M, Weiss C, Schuld J, Rau BM (2014) Liver resections of isolated liver metastases in breast cancer: results and possible prognostic factors. HPB Surg 2014:893829
Largillier R, Ferrero JM, Doyen J, Barriere J, Namer M, Mari V, Courdi A, Hannoun-Levi JM, Ettore F, Birtwisle-Peyrottes I, Balu-Maestro C, Marcy PY, Raoust I, Lallement M, Chamorey E (2008) Prognostic factors in 1038 women with metastatic breast cancer. Ann Oncol 19(12):2012–2019
Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics. CA Cancer J Clin 60:277–300
Leiter U, Meier F, Schittek B, Garbe C (2004) The natural course of cutaneous melanoma. J Surg Oncol 86:172–178
Aubin JM, Rekman J, Vandenbroucke-Menu F, Lapointe R, Fairfull-Smith RJ, MimeaultR Balaa FK, Martel G (2013) Systematic review and meta-analysis of liver resection for metastatic melanoma. Br J Surg 100:1138–1147
Rose DM, Essner R, Hughes TM, Tang PC, Bilchik A, Wanek LA, Thompson JF, Morton DL (2001) Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg 136(8):950–955
Rivoire M, Kodjikian L, Baldo S, Kaemmerlen P, Négrier S, Grange JD (2005) Treatment of liver metastases from uveal melanoma. Ann Surg Oncol 12(6):422–428 (Epub 2005 May 5)
Adam R, Chiche L, Aloia T, Elias D, Salmon R, Rivoire M, Jaeck D, Saric J, Le Treut YP, Belghiti J, Mantion G, Mentha G, Association Française de Chirurgie (2006) Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg 244(4):524–535
Pawlik TM, Zorzi D, Abdalla EK, Clary BM, Gershenwald JE, Ross MI, Aloia TA, Curley SA, Camacho LH, Capussotti L, Elias D, Vauthey JN (2006) Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncol 13(5):712–720
Frenkel S, Nir I, Hendler K, Lotem M, Eid A, Jurim O, Pe’er J (2009) Long-term survival of uveal melanoma patients after surgery for liver metastases. Br J Ophthalmol 93(8):1042–1046
Mariani P, Piperno-Neumann S, Servois V, Berry MG, Dorval T, Plancher C, Couturier J, Levy-Gabriel C, Lumbroso-Le Rouic L, Desjardins L, Salmon RJ (2009) Surgical management of liver metastases from uveal melanoma: 16 years’ experience at the Institut Curie. Eur J Surg Oncol 35(11):1192–1197
Ripley RT, Davis JL, Klapper JA, Mathur A, Kammula U, Royal RE, Yang JC, Sherry RM, Hughes MS, Libutti SK, White DE, Steinberg SM, Dudley ME, Rosenberg SA, Avital I (2010) Liver resection for metastatic melanoma with postoperative tumour-infiltrating lymphocyte therapy. Ann Surg Oncol 17(1):163–170
de Ridder J, van Walsum M, Verhoef C, Nagtegaal I, de Wilt J, Dutch Liver Working Group (2013) Hepatic resection for metastatic melanoma in The Netherlands: survival and prognostic factors. Melanoma Res 23(1):27–32
Ryu SW, Saw R, Scolyer RA, Crawford M, Thompson JF, Sandroussi C (2013) Liver resection for metastatic melanoma: equivalent survival for cutaneous and ocular primaries. J Surg Oncol 108(2):129–135
Faries MB, Leung A, Morton DL, Hari D, Lee JH, Sim MS, Bilchik AJ (2014) A 20-year experience of hepatic resection for melanoma: is there an expanding role? J Am Coll Surg 219(1):62–68
Servois V, Mariani P, Malhaire C, Petras S, Piperno-Neumann S, Plancher C, Levy-Gabriel C, Lumbroso-le Rouic L, Desjardins L, Salmon RJ (2010) Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET). EJSO 36:189–194
Bonnefoi H, A’Hern RP, Fisher C, Macfarlane V, Barton D, Blake P, Shepherd JH, Gore ME (1999) Natural history of stage IV epithelial ovarian cancer. J Clin Oncol 17(3):767–775
Hatzaras I, Gleisner AL, Pulitano C, Sandroussi C, Hirose K, Hyder O, Wolfgang CL, Aldrighetti L, Crawford M, Choti MA, Pawlik MT (2012) A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell carcinoma. HPB 14:532–538
Alves A, Adam R, Majno P, Delvart V, Azoulay D, Castaing D, Bismuth H (2003) Hepatic resection for metastatic renal tumours: is it worthwhile? Ann Surg Oncol 10:705–710
Merideth MA, Cliby WA, Keeney GL, Lesnik TG, Nagorney DM, Podratz KC (2003) Hepatic resection for metachronous metastases from ovarian carcinoma. Gynecol Oncol 89(1):16–21
Weitz J, Blumgart LH, Fong Y, Jarnagin WR, D’Angelica M, Harrison LE, DeMatteo RP (2005) Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma. Ann Surg 241(2):269–276
Aloia TA, Adam R, Azoulay D, Bismuth H, Castaing D (2006) Outcome following hepatic resection of metastatic renal tumours: the Paul Brousse Hospital experience. HPB 8:100–105
Thelen A, Jonas S, Benckert C, Lopez-Hanninen E, Rudolph B, Neumann U, Neuhaus P (2007) Liver resection for metastases from renal cell carcinoma. World J Surg 31:802–807
Staehler MD, Kruse J, Haseke N, Stadler T, Roosen A, Karl A, Stief CG, Jauch KW, Bruns CJ (2010) Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis. World J Urol 28:543–547
Ruys AT, Tanis PJ, Iris ND, van Duijvendijk P, Verhoef C, Porte RJ, van Gulik TM (2011) Surgical treatment of renal cell cancer liver metastases: a population-based study. Ann Surg Oncol 18:1932–1938
Roh HJ, Kim DY, Joo WD, Yoo HJ, Kim JH, Kim YM, Kim Y-Y, Nam JH (2011) Hepatic resection as part of secondary cytoreductive surgery for recurrent ovarian cancer involving the liver. Arch Gymecol Obstet 284:1223–1229
Kamel SI, de Jong MC, Schulick RD, Diaz-Montes TP, Wolfgang CL, Hirose K, Edil BH, Choti MA, Anders RA, Pawlik TM (2011) The role of liver-directed surgery in patients with hepatic metastasis from a gynecologic primary carcinoma. World J Surg 35(6):1345–1354
Langan RC, Ripley RT, Davis JL, Prieto PA, Datrice N, Steinberg SM, Bratslavsky G, Rudloff U, Kammula US, Stojadinovic A, Avital I (2012) Liver directed therapy for renal cell carcinoma. J Cancer 3:184–190
Krikelis D, Judson I (2010) Role of chemotherapy in the management of soft tissue sarcomas. Expert Rev Anticancer Ther 10(2):249–260
Nystrom LM, Reimer NB, Reith JD, Dang L, Zlotecki RA, Scarborough MT, Gibbs CP Jr (2013) Multidisciplinary management of soft tissue sarcoma. Sci World J 28(2013):852462
Lang H, Nussbaum KT, Kaudel P, Frühauf N, Flemming P, Raab R (2000) Hepatic metastases from leiomyosarcoma: a single-center experience with 34 liver resections during a 15-year period. Ann Surg 231(4):500–505
DeMatteo RP, Shah A, Fong Y, Jarnagin WR, Blumgart LH, Brennan MF (2001) Results of hepatic resection for sarcoma metastatic to liver. Ann Surg 234(4):540–547
Goering JD, Mahvi DM, Niederhuber JE, Chicks D, Rikkers LF (2002) Cryoablation and liver resection for noncolorectal liver metastases. Am J Surg 183(4):384–389
Yedibela S, Gohl J, Graz V, Pfaffenberger MK, Merkel S, Hohenberger W, Meyer T (2005) Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumours: a single-institutional review. Ann Surg Oncol 12(10):778–785
Ercolani G, Grazi GL, Ravaioli M, Ramacciato G, Cescon M, Varotti G, Del Gaudio M, Vetrone G, Pinna AD (2005) The role of liver resections for noncolorectal, nonneuroendocrine metastases: experience with 142 observed cases. Ann Surg Oncol 12(6):459–466
Pawlik TM, Vauthey JN, Abdalla EK, Pollock RE, Ellis LM, Curley SA (2006) Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver. Arch Surg 141(6):537–543
Lendoire J, Moro M, Andriani O, Grondona J, Gil O, Raffin G, Silva J, Bracco R, Podestá G, Valenzuela C, Imventarza O, Pekolj J, De Santibañes E (2007) Liver resection for non-colorectal, non-neuroendocrine metastases: analysis of a multicenter study from Argentina. HPB Oxf 9(6):435–439
Rehders A, Peiper M, Stoecklein NH, Alexander A, Boelke E, Knoefel WT, Rogiers X (2009) Hepatic metastasectomy for soft-tissue sarcomas: is it justified? World J Surg 33(1):111–117
Zacherl M, Bernhardt GA, Zacherl J, Gruber G, Kornprat P, Bacher H, Mischinger HJ, Windhager R, Jakesz R, Grünberger T (2011) Surgery for liver metastases originating from sarcoma-case series Langenbecks. Arch Surg 396(7):1083–1091
Turley RS, Peng PD, Reddy SK, Barbas AS, Geller DA, Marsh JW, Tsung A, Pawlik TM, Clary BM (2012) Hepatic resection for metastatic gastrointestinal stromal tumours in the tyrosine kinase inhibitor era. Cancer 118(14):3571–3578
Ripley RT, Kemp CD, Davis JL, Langan RC, Royal RE, Libutti SK, Steinberg SM, Wood BJ, Kammula US, Fojo T, Avital I (2011) Liver resection and ablation for metastatic adrenocortical carcinoma. Ann Surg Oncol 18(7):1972–1979
Gaujoux S, Al-Ahmadie H, Allen PJ, Gonen M, Shia J, D’Angelica M, Dematteo R, Fong Y, Blumgart L, Jarnagin WR (2012) Resection of adrenocortical carcinoma liver metastases: is it justified? Ann Surg Oncol 19(8):2643–2651
O’Rourke TR, Tekkis P, Yeung S, Fawcett J, Lynch S, Strong R, Wall D, John TG, Welsh F, Rees M (2008) Long-term results of liver resection for non-colorectal, non neuroendocrine metastases. Ann Surg Oncol 15:207–218
Hoang T, Xu R, Schiller JH, Johnson DH (2005) Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on Eastern Cooperative Oncology Group Data. J Clin Oncol 23:175–183
Goéré D, Elias D (2008) Resection of liver metastases from non-colorectal non-endocrine primary tumours. Eur J Surg Oncol 34(3):281–288
Page AJ, Weiss MJ, Pawlik TM (2014) Surgical management of noncolorectal cancer liver metastases. Cancer 120(20):3111–3121
Fitzgerald TL, Brinkley J, Banks S, Vohra N, Englert ZP, Zervos EE (2014) The benefits of liver resection for non-colorectal, non-neuroendocrine liver metastases: a systematic review. Langenbecks Arch Surg 399(8):989–1000
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they don’t have any conflict of interest.
Ethical standard
All procedures followed were in accordance with the ethical standards of responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.
Research involving human participants and/or animals
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
No informed consent is required.
Rights and permissions
About this article
Cite this article
Neri, F., Ercolani, G., Di Gioia, P. et al. Liver metastases from non-gastrointestinal non-neuroendocrine tumours: review of the literature. Updates Surg 67, 223–233 (2015). https://doi.org/10.1007/s13304-015-0315-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13304-015-0315-2